Literature DB >> 33349988

Disclosure experience among COVID-19-confirmed patients in China: A qualitative study.

Wenxiu Sun1, Ying Zhou1, Wei-Ti Chen2, Feifei Huang3, Meiyan Sun1, Lei Shen1, Yan Gao1, Qing Zhang1, Siyue Ma1, Chengshi Shiu4, Lin Zhang1, Hongzhou Lu1.   

Abstract

AIM: To understand COVID patients' experiences of and perspectives on disclosure of their illness and to explore and describe the factors affecting disclosure decisions among COVID patients in China.
BACKGROUND: Disease disclosure is a critical component of prevention and control of a virus outbreak, and this is especially true during the COVID-19 pandemic. Understanding COVID patients' experiences and perspectives on disclosure could play a vital role in COVID management.
DESIGN: A qualitative study.
METHODS: A semi-structured interview guide was used to conduct qualitative in-depth interviews from April to June 2020. All the interviews were audio-recorded and transcribed, and then, a thematic analysis was conducted. The Standards for Reporting Qualitative Research (SRQR) were applied to this study.
RESULTS: A total of 26 COVID-confirmed patients were recruited for the in-depth interviews. Four themes emerged from the thematic analysis on disclosure: persons disclosed to, reasons for disclosure, reasons for nondisclosure and impact of disclosure. The participants disclosed their COVID diagnosis to different groups, including family, close friends, community members and workplace contacts. The main reasons for disclosure included the following: government policy, social responsibility, gaining support and fear of being blamed for nondisclosure. However, some participants decided not to disclose to some groups for fear of facing stigma and discrimination or to protect family members from discrimination. Despite the potential benefits of obtaining support after disclosure, many participants did experience stigma and discrimination, privacy exposure, psychological distress and social isolation.
CONCLUSIONS: An individual's decision as to whether to disclose their COVID-positive status is affected by many factors. To prevent the spread of COVID-19 and reduce the potential risks of disclosure, such as discrimination and privacy exposure, a balanced intervention should be designed to protect COVID patients and to secure any contact tracing. Therefore, the chances of discrimination could be decreased and patients' confidentiality could be protected. RELEVANCE TO CLINICAL PRACTICE: As the number of COVID patients increases, disclosure of an individual's infectious status is encouraged by health departments. Despite the potential benefits of disclosure, discrimination and privacy exposure should not be ignored. A disclosure protocol is necessary to ensure patients' privacy regarding their COVID status.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID; China; disclosure; qualitative study

Mesh:

Year:  2021        PMID: 33349988      PMCID: PMC9205648          DOI: 10.1111/jocn.15616

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   4.423


  31 in total

Review 1.  Factors influencing HIV disclosure among people living with HIV/AIDS in Nigeria: a systematic review using narrative synthesis and meta-analysis.

Authors:  D I Adeoye-Agboola; H Evans; D Hewson; Y Pappas
Journal:  Public Health       Date:  2016-04-05       Impact factor: 2.427

2.  A qualitative insight of HIV/AIDS patients' perspective on disease and disclosure.

Authors:  Imran Ahmed Syed; Syed Azhar Syed Sulaiman; Mohammad Azmi Hassali; Kaeshalya Thiruchelvum; Christopher K C Lee
Journal:  Health Expect       Date:  2014-09-17       Impact factor: 3.377

3.  Gender differences in HIV disclosure, stigma, and perceptions of health.

Authors:  Cindy Geary; Warren Parker; Susan Rogers; Erica Haney; Carolyne Njihia; Amaha Haile; Eddy Walakira
Journal:  AIDS Care       Date:  2014-06-12

4.  Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.

Authors:  Peter A McCullough; John Eidt; Janani Rangaswami; Edgar Lerma; James Tumlin; Kevin Wheelan; Nevin Katz; Norman E Lepor; Kris Vijay; Sandeep Soman; Bhupinder Singh; Sean P McCullough; Haley B McCullough; Alberto Palazzuoli; Gaetano M Ruocco; Claudio Ronco
Journal:  Rev Cardiovasc Med       Date:  2020-03-30       Impact factor: 2.930

5.  The efficacy of serostatus disclosure for HIV Transmission risk reduction.

Authors:  Ann A O'Connell; Sandra J Reed; Julianne A Serovich
Journal:  AIDS Behav       Date:  2015-02

6.  Social support, stigma, and HIV disclosure among parents living with HIV in Guangxi, China.

Authors:  Yuchen Mao; Xiaoming Li; Shan Qiao; Qun Zhao; Yuejiao Zhou; Zhiyong Shen
Journal:  AIDS Care       Date:  2017-10-11

7.  HIV serostatus disclosure among people living with HIV/AIDS in Mwanza, Tanzania.

Authors:  Gladys Yonah; Francis Fredrick; Germana Leyna
Journal:  AIDS Res Ther       Date:  2014-01-22       Impact factor: 2.250

Review 8.  Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.

Authors:  Jia Wang; Zhifeng Wang
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

Review 9.  Systematic review of beliefs, behaviours and influencing factors associated with disclosure of a mental health problem in the workplace.

Authors:  Elaine Brohan; Claire Henderson; Kay Wheat; Estelle Malcolm; Sarah Clement; Elizabeth A Barley; Mike Slade; Graham Thornicroft
Journal:  BMC Psychiatry       Date:  2012-02-16       Impact factor: 3.630

10.  Patients with mental health disorders in the COVID-19 epidemic.

Authors:  Hao Yao; Jian-Hua Chen; Yi-Feng Xu
Journal:  Lancet Psychiatry       Date:  2020-04       Impact factor: 27.083

View more
  6 in total

1.  COVID-19-related Stigma Among the Affected Individuals: A Cross-Sectional Study From Kerala, India.

Authors:  Nimmy Chandran; Sajal Sathiadevan
Journal:  Indian J Psychol Med       Date:  2022-05-08

2.  Delineating privacy aspects of COVID tracing applications embedded with proximity measurement technologies & digital technologies.

Authors:  Tahereh Saheb; Elham Sabour; Fatimah Qanbary; Tayebeh Saheb
Journal:  Technol Soc       Date:  2022-03-19

3.  Kopfkino: Phases of quarantine among asymptomatic SARS-COV-2 carriers in Germany.

Authors:  Ferdinand Uellner; Freda Röhr; Claudia Denkinger; Till Bärnighausen; Andreas Deckert; Aurelia Souares; Shannon A McMahon
Journal:  SSM Qual Res Health       Date:  2022-03-22

4.  COVID-19 perceived stigma among survivors: A cross-sectional study of prevalence and predictors.

Authors:  Mohamad Alchawa; Sarah Naja; Khaled Ali; Vahe Kehyayan; Peter Michael Haddad; Iheb Bougmiza
Journal:  Eur J Psychiatry       Date:  2022-08-30

5.  Conceptualizing the COVID-19 Pandemic: Perspectives of Pregnant and Lactating Women, Male Community Members, and Health Workers in Kenya.

Authors:  Alicia M Paul; Clarice Lee; Berhaun Fesshaye; Rachel Gur-Arie; Eleonor Zavala; Prachi Singh; Ruth A Karron; Rupali J Limaye
Journal:  Int J Environ Res Public Health       Date:  2022-08-30       Impact factor: 4.614

6.  The Experience of Patients with COVID-19 in China: An Interpretative Phenomenological Analysis.

Authors:  Yanbo Wang; Xiao Pan; Yonghai Bai
Journal:  Psychol Res Behav Manag       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.